Cargando…

Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer

BACKGROUND: The incidence rate of gastric cancer in western countries has shown a remarkable decline in the recent years while it is still the most common cancer among males in Iran. The proto-oncogene MYC, located at 8q24.1, regulates almost 15% of human genes and is activated in 20% of all tumors....

Descripción completa

Detalles Bibliográficos
Autores principales: Khaleghian, Malihea, Jahanzad, Issa, Shakoori, Abbas, Emami Razavi, Amirnader, Azimi, Cyrus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863201/
https://www.ncbi.nlm.nih.gov/pubmed/27175302
http://dx.doi.org/10.5812/ircmj.21221
_version_ 1782431449307152384
author Khaleghian, Malihea
Jahanzad, Issa
Shakoori, Abbas
Emami Razavi, Amirnader
Azimi, Cyrus
author_facet Khaleghian, Malihea
Jahanzad, Issa
Shakoori, Abbas
Emami Razavi, Amirnader
Azimi, Cyrus
author_sort Khaleghian, Malihea
collection PubMed
description BACKGROUND: The incidence rate of gastric cancer in western countries has shown a remarkable decline in the recent years while it is still the most common cancer among males in Iran. The proto-oncogene MYC, located at 8q24.1, regulates almost 15% of human genes and is activated in 20% of all tumors. The amplification of MYC and overexpression of its protein product are observed in 15 - 30% of gastric neoplasias. OBJECTIVES: The objective of this study was to find the preferences of Chromogenic In Situ Hybridization (CISH) and Immunohistochemistry (IHC) in diagnosis and prognosis of gastric cancer. PATIENTS AND METHODS: We studied 102 samples of gastric cancer in Iran and all the patients had undergone primary surgical resection at the Cancer Institute Hospital, Tehran University of Medical Sciences. The CISH and IHC techniques were applied for all our samples. All of the samples had adenocarcinoma gastric cancer and were selected randomly. Also, the type of study was cross sectional. The sample size was 100 patients. RESULTS: Our data revealed that both diffuse and intestinal types of gastric cancer occurred significantly more in males than females. Our results showed that there was an indication of some correlation between grades and CISH, although the difference was not significant. Our data also showed that CISH positive patients (43%) were more frequent compared to IHC positive patients (14.7%). There was a correlation between CISH and IHC. These results revealed that there was a significant difference between grades and IHC. There was also no statistical difference between CISH amplification in diffuse and intestinal types. CONCLUSIONS: From the results, it could be concluded that for administration of the treatment of stomach cancer, and progress and prognosis of tumor, which is important for patients and clinicians, the CISH is a better and more feasible test than IHC, in regards to sensitivity and specificity.
format Online
Article
Text
id pubmed-4863201
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-48632012016-05-12 Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer Khaleghian, Malihea Jahanzad, Issa Shakoori, Abbas Emami Razavi, Amirnader Azimi, Cyrus Iran Red Crescent Med J Research Article BACKGROUND: The incidence rate of gastric cancer in western countries has shown a remarkable decline in the recent years while it is still the most common cancer among males in Iran. The proto-oncogene MYC, located at 8q24.1, regulates almost 15% of human genes and is activated in 20% of all tumors. The amplification of MYC and overexpression of its protein product are observed in 15 - 30% of gastric neoplasias. OBJECTIVES: The objective of this study was to find the preferences of Chromogenic In Situ Hybridization (CISH) and Immunohistochemistry (IHC) in diagnosis and prognosis of gastric cancer. PATIENTS AND METHODS: We studied 102 samples of gastric cancer in Iran and all the patients had undergone primary surgical resection at the Cancer Institute Hospital, Tehran University of Medical Sciences. The CISH and IHC techniques were applied for all our samples. All of the samples had adenocarcinoma gastric cancer and were selected randomly. Also, the type of study was cross sectional. The sample size was 100 patients. RESULTS: Our data revealed that both diffuse and intestinal types of gastric cancer occurred significantly more in males than females. Our results showed that there was an indication of some correlation between grades and CISH, although the difference was not significant. Our data also showed that CISH positive patients (43%) were more frequent compared to IHC positive patients (14.7%). There was a correlation between CISH and IHC. These results revealed that there was a significant difference between grades and IHC. There was also no statistical difference between CISH amplification in diffuse and intestinal types. CONCLUSIONS: From the results, it could be concluded that for administration of the treatment of stomach cancer, and progress and prognosis of tumor, which is important for patients and clinicians, the CISH is a better and more feasible test than IHC, in regards to sensitivity and specificity. Kowsar 2016-01-01 /pmc/articles/PMC4863201/ /pubmed/27175302 http://dx.doi.org/10.5812/ircmj.21221 Text en Copyright © 2016, Iranian Red Crescent Medical Journal. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Khaleghian, Malihea
Jahanzad, Issa
Shakoori, Abbas
Emami Razavi, Amirnader
Azimi, Cyrus
Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer
title Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer
title_full Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer
title_fullStr Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer
title_full_unstemmed Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer
title_short Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer
title_sort association between amplification and expression of c-myc gene and clinicopathological characteristics of stomach cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863201/
https://www.ncbi.nlm.nih.gov/pubmed/27175302
http://dx.doi.org/10.5812/ircmj.21221
work_keys_str_mv AT khaleghianmalihea associationbetweenamplificationandexpressionofcmycgeneandclinicopathologicalcharacteristicsofstomachcancer
AT jahanzadissa associationbetweenamplificationandexpressionofcmycgeneandclinicopathologicalcharacteristicsofstomachcancer
AT shakooriabbas associationbetweenamplificationandexpressionofcmycgeneandclinicopathologicalcharacteristicsofstomachcancer
AT emamirazaviamirnader associationbetweenamplificationandexpressionofcmycgeneandclinicopathologicalcharacteristicsofstomachcancer
AT azimicyrus associationbetweenamplificationandexpressionofcmycgeneandclinicopathologicalcharacteristicsofstomachcancer